JP2023535684A5 - - Google Patents
Info
- Publication number
- JP2023535684A5 JP2023535684A5 JP2023503042A JP2023503042A JP2023535684A5 JP 2023535684 A5 JP2023535684 A5 JP 2023535684A5 JP 2023503042 A JP2023503042 A JP 2023503042A JP 2023503042 A JP2023503042 A JP 2023503042A JP 2023535684 A5 JP2023535684 A5 JP 2023535684A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antigen
- amino acid
- acid sequence
- binding moiety
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063053286P | 2020-07-17 | 2020-07-17 | |
| US63/053,286 | 2020-07-17 | ||
| PCT/IB2021/056418 WO2022013819A1 (en) | 2020-07-17 | 2021-07-15 | Anti-idiotypic antibodies against anti-gprc5d antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026057713A Division JP2026129698A (ja) | 2020-07-17 | 2026-03-31 | 抗ｇｐｒｃ５ｄ抗体に対する抗イディオタイプ抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023535684A JP2023535684A (ja) | 2023-08-21 |
| JP2023535684A5 true JP2023535684A5 (enExample) | 2024-06-25 |
| JP7844430B2 JP7844430B2 (ja) | 2026-04-13 |
Family
ID=77499865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023503042A Active JP7844430B2 (ja) | 2020-07-17 | 2021-07-15 | 抗ｇｐｒｃ５ｄ抗体に対する抗イディオタイプ抗体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12030937B2 (enExample) |
| EP (1) | EP4225801A1 (enExample) |
| JP (1) | JP7844430B2 (enExample) |
| CN (1) | CN115884987A (enExample) |
| CA (1) | CA3189562A1 (enExample) |
| IL (1) | IL299894A (enExample) |
| WO (1) | WO2022013819A1 (enExample) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| ES2246502T3 (es) | 1990-08-29 | 2006-02-16 | Genpharm International, Inc. | Animales no humanos transgenicos capaces de producir anticuerpos heterologos. |
| US6265150B1 (en) | 1995-06-07 | 2001-07-24 | Becton Dickinson & Company | Phage antibodies |
| US5714352A (en) | 1996-03-20 | 1998-02-03 | Xenotech Incorporated | Directed switch-mediated DNA recombination |
| WO2001058479A1 (en) | 2000-02-08 | 2001-08-16 | The Penn State Research Foundation | Immunotherapy using interleukin 13 receptor subunit alpha 2 |
| JP5838021B2 (ja) | 2005-04-15 | 2015-12-24 | マクロジェニクス，インコーポレーテッド | 共有結合型ダイアボディとその使用 |
| US9963510B2 (en) | 2005-04-15 | 2018-05-08 | Macrogenics, Inc. | Covalent diabodies and uses thereof |
| AU2008343589A1 (en) | 2007-12-19 | 2009-07-09 | Centocor Ortho Biotech Inc. | Design and generation of human de novo pIX phage display libraries via fusion to pIX or pVII, vectors, antibodies and methods |
| HRP20200583T1 (hr) * | 2015-03-20 | 2020-07-10 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Protutijela koja neutraliziraju gp120 i njihova upotreba |
| TWI781108B (zh) * | 2016-07-20 | 2022-10-21 | 比利時商健生藥品公司 | 抗ｇｐｒｃ５ｄ抗體、結合ｇｐｒｃ５ｄ與ｃｄ３之雙特異性抗原結合分子及其用途 |
| MA45784A (fr) * | 2016-07-29 | 2019-06-05 | Juno Therapeutics Inc | Anticorps anti-idiotypes dirigés contre anti-cd19 anticorps |
| TW201837174A (zh) * | 2017-02-07 | 2018-10-16 | 日商第一三共股份有限公司 | 抗ｇｐｒｃ５ｄ抗體及包含該抗體之分子 |
| US12077592B2 (en) * | 2019-01-18 | 2024-09-03 | Janssen Biotech, Inc. | GPRC5D chimeric antigen receptors and cells expressing the same |
| WO2021113780A1 (en) | 2019-12-06 | 2021-06-10 | Juno Therapeutics, Inc. | Anti-idiotypic antibodies to gprc5d-targeted binding domains and related compositions and methods |
-
2021
- 2021-07-15 WO PCT/IB2021/056418 patent/WO2022013819A1/en not_active Ceased
- 2021-07-15 CN CN202180049442.3A patent/CN115884987A/zh active Pending
- 2021-07-15 JP JP2023503042A patent/JP7844430B2/ja active Active
- 2021-07-15 CA CA3189562A patent/CA3189562A1/en active Pending
- 2021-07-15 US US17/376,874 patent/US12030937B2/en active Active
- 2021-07-15 IL IL299894A patent/IL299894A/en unknown
- 2021-07-15 EP EP21759387.0A patent/EP4225801A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109336973B (zh) | 抗转铁蛋白抗体及其用途 | |
| CN116813780B (zh) | 抗人cd31兔单克隆抗体及其应用 | |
| CN119219784A (zh) | 抗西酞普兰的抗体或其抗原结合片段及其应用 | |
| CN106939034A (zh) | 用于鉴定受试者所感染的hev基因型的方法和试剂盒 | |
| CN118440188B (zh) | 抗新型冠状病毒或其n蛋白抗体、检测新型冠状病毒或其n蛋白的试剂和试剂盒 | |
| WO2024020194A1 (en) | Compositions and methods for detecting dsrna | |
| CN111892657B (zh) | 用于检测米田堡血型抗原的抗体及其片段、试剂盒及方法 | |
| TWI741216B (zh) | 專一性抑制或減緩ｐｔｘ３與ｐｔｘ３受體結合之單株抗體或其抗原結合片段及其用途 | |
| CN119019551B (zh) | 抗cTnI抗体、检测cTnI的试剂和试剂盒 | |
| TWI869740B (zh) | 一種體外檢測ｓＴＮＦＲ２蛋白濃度的方法及其檢測試劑和檢測試劑盒 | |
| CN119039439B (zh) | 抗人细胞间黏附分子-1抗体、抗体对及其应用 | |
| CN119285762B (zh) | 抗cTnI抗体、检测cTnI的试剂和试剂盒 | |
| CN119431580B (zh) | 一种抗人tigit单克隆抗体及其应用 | |
| CN118440189B (zh) | 抗p24抗体、检测p24的试剂和试剂盒 | |
| CN121319191B (zh) | Pla2r的ctld7结构域特异性抗体及其应用 | |
| CN119569878B (zh) | 一种抗sST2抗体及其应用 | |
| KR102798983B1 (ko) | 사스 코로나바이러스 2 스파이크 항원에 특이적으로 결합하는 항체 및 이의 용도 | |
| CN119504988B (zh) | 一种抗心肌肌钙蛋白i抗体及其应用 | |
| KR102798975B1 (ko) | 사스 코로나바이러스 2 스파이크 항원에 특이적으로 결합하는 항체 및 이의 용도 | |
| CN111434686A (zh) | 一种抗人pbx1单克隆抗体，其制备方法及其在复发性流产临床诊断中的用途 | |
| RU2023134705A (ru) | Антиидиотипические антитела против антител к cd79b | |
| CN121045369A (zh) | 新冠病毒n蛋白的特异性抗体及其应用 | |
| CN119505006A (zh) | 抗喹硫平的抗体或其抗原结合片段及其应用 | |
| CN119119282A (zh) | 抗2c-b的抗体或其抗原结合片段及其应用 | |
| CN120424205A (zh) | 一种抗cTnI的抗体及其应用 |